Milestone for women’s HIV prevention: European Medicines Agency gives dapivirine ring the OK

A monthly vaginal ring is one significant step closer to potentially becoming a new HIV prevention method for cisgender women in sub-Saharan Africa, who face persistently high rates of HIV infection but have few options to protect themselves. Story highlights work from Biostatistics researchers Elizabeth Brown and Barbra Richardson.